Literature DB >> 31879492

Expression pattern of Syndecan-1 and HSP-70 in hip tissue of patients with osteoarthritis.

Julian Kaufman1, Davor Caric2, Katarina Vukojevic1.   

Abstract

OBJECTIVES: We investigated the expression of Syndecan-1 and HSP-70 in synovial, chondral and subchondral tissue in the hips of patients with osteoarthritis (OA).
METHODS: Total hip arthroplasty was performed on 6 patients and 3 controls. Patients were divided into two groups according to disease severity. The tissues were immunohistochemically analyzed.
RESULTS: Cartilage and subchondral tissue in patients with severe OA contained abundant positive cells with a mean positive percentage of 94,51 ± 5% and 78,95 ± 14% for Syndecan-1 and 94,42 ± 5% and 75,67 ± 17% for HSP-70, respectively.
CONCLUSION: In conclusion, HSP-70 and Syndecan-1 might play a role in the onset and regulation of OA in the hip.
© 2019 Professor P K Surendran Memorial Education Foundation. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cartilage; HSP-70; Hip; Osteoarthritis; Subchondral tissue; Syndecan-1

Year:  2019        PMID: 31879492      PMCID: PMC6919396          DOI: 10.1016/j.jor.2019.08.019

Source DB:  PubMed          Journal:  J Orthop        ISSN: 0972-978X


  12 in total

1.  Gene transfer with HSP 70 in rat chondrocytes confers cytoprotection in vitro and during experimental osteoarthritis.

Authors:  Laurent Grossin; Christel Cournil-Henrionnet; Astrid Pinzano; Nadège Gaborit; Dominique Dumas; Stéphanie Etienne; Jean François Stoltz; Bernard Terlain; Patrick Netter; Lluis M Mir; Pierre Gillet
Journal:  FASEB J       Date:  2006-01       Impact factor: 5.191

2.  Syndecan-1 expression is upregulated in degenerating articular cartilage in a transgenic mouse model for osteoarthritis.

Authors:  H Salminen-Mankonen; A-M Säämänen; M Jalkanen; E Vuorio; L Pirilä
Journal:  Scand J Rheumatol       Date:  2005 Nov-Dec       Impact factor: 3.641

3.  Immunohistochemical characterization of early and advanced knee osteoarthritis by NF-κB and iNOS expression.

Authors:  Marko Ostojic; Violeta Soljic; Katarina Vukojevic; Tomislav Dapic
Journal:  J Orthop Res       Date:  2017-05-03       Impact factor: 3.494

Review 4.  Osteoarthritis.

Authors:  Duarte Pereira; Elisabete Ramos; Jaime Branco
Journal:  Acta Med Port       Date:  2015-02-27

5.  Circulating and Synovial Fluid Heat Shock Protein 70 Are Correlated with Severity in Knee Osteoarthritis.

Authors:  Srihatach Ngarmukos; Shaun Scaramuzza; Nipaporn Theerawattanapong; Aree Tanavalee; Sittisak Honsawek
Journal:  Cartilage       Date:  2018-07-19       Impact factor: 4.634

6.  Analysis of heat shock proteins and cytokines expressed during early stages of osteoarthritis in a mouse model.

Authors:  K Takahashi; T Kubo; R S Goomer; D Amiel; K Kobayashi; J Imanishi; R Teshima; Y Hirasawa
Journal:  Osteoarthritis Cartilage       Date:  1997-09       Impact factor: 6.576

Review 7.  Measures of hip function and symptoms: Harris Hip Score (HHS), Hip Disability and Osteoarthritis Outcome Score (HOOS), Oxford Hip Score (OHS), Lequesne Index of Severity for Osteoarthritis of the Hip (LISOH), and American Academy of Orthopedic Surgeons (AAOS) Hip and Knee Questionnaire.

Authors:  Anna Nilsdotter; Ann Bremander
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-11       Impact factor: 4.794

Review 8.  Knee osteoarthritis: pathophysiology and current treatment modalities.

Authors:  Juan C Mora; Rene Przkora; Yenisel Cruz-Almeida
Journal:  J Pain Res       Date:  2018-10-05       Impact factor: 3.133

9.  Downregulation of heat shock protein 70 protects rheumatoid arthritis fibroblast-like synoviocytes from nitric oxide-induced apoptosis.

Authors:  Eun Ha Kang; Dong Jo Kim; Eun Young Lee; Yun Jong Lee; Eun Bong Lee; Yeong Wook Song
Journal:  Arthritis Res Ther       Date:  2009-08-27       Impact factor: 5.156

Review 10.  Hip Osteoarthritis: Etiopathogenesis and Implications for Management.

Authors:  Nicholas J Murphy; Jillian P Eyles; David J Hunter
Journal:  Adv Ther       Date:  2016-09-26       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.